FDA Approves ASCENIV(formerly referred to as RI-002), A Novel Intravenous Immune Globulin

See the Press Release

Groundbreaking Immunotechnology,
One Connection at a Time.

Superior Solutions Come From Superior Commitment

ADMA Biologics is a biopharmaceutical company relentlessly committed to creating superior products for immunodeficient patients at risk for infection. It is our devotion to this underserved population that fuels us, and our hands-on approach to production and development that sets us apart.

Why does it matter? Because patients are counting on us.